TSW
AFIB

Thompson Siegel & Walmsley’s Acutus Medical Inc AFIB Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-53,000
Closed -$181K – 686
2021
Q4 		$181K Buy
53,000
+15,000
+39% +$84.5K ﹤0.01% 383
2021
Q3 		$336K Buy
+38,000
New +$500K ﹤0.01% 336

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Thompson Siegel & Walmsley's AFIB Position: Q1 2022 in Review

Thompson Siegel & Walmsley sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 53,000 shares — an estimated $181K sold.

Thompson Siegel & Walmsley first reported a position in AFIB in Q3 2021 and held it in 2 quarters. The position peaked at $336K in Q3 2021. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

  • Thompson Siegel & Walmsley reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 53,000 Acutus Medical Inc shares in Q1 2022, an estimated $181K.
  • Thompson Siegel & Walmsley first reported a position in Acutus Medical Inc in Q3 2021 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's Acutus Medical Inc position peaked at $336K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2022, filed 26 Apr 2022.